Aldeyra Therapeutics, Inc.

ALDX·NASDAQ·$1.78Share Price as of 11/2·$107MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/27/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report07/30/26 8-KCurrent report07/15/26 8-KCurrent report06/10/26 8-KCurrent report05/01/26

Prospectuses and Registrations

S-8Registration of securities for employees02/27/26 S-8Registration of securities for employees02/28/25 424B5Prospectus supplement08/01/24 S-3Shelf registration03/07/24 S-8Registration of securities for employees03/07/24

Proxies

DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/22/24

Ownership

SC 13GBeneficial ownership08/12/26 Form 3Initial insider ownership06/11/26 Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26 Form 4Insider transaction06/11/26

Other

ARSAnnual report to shareholders04/27/26 ARSAnnual report to shareholders04/25/25 EFFECTRequest for effectiveness04/24/24 ARSAnnual report to shareholders04/22/24 CORRESPCorrespondence with the SEC04/22/24